Ranolazine
Ranexa, Latixa (ranolazine) is a small molecule pharmaceutical. Ranolazine was first approved as Ranexa on 2006-01-27. It is used to treat angina pectoris in the USA. It has been approved in Europe to treat angina pectoris.
| Trade Name | Latixa, Ranexa |
|---|---|
| Common Name | Ranolazine |
| Indication | angina pectoris |
| Drug Class | Antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure |
